Raynald Samoa

696 total citations
29 papers, 470 citations indexed

About

Raynald Samoa is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Sociology and Political Science. According to data from OpenAlex, Raynald Samoa has authored 29 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Molecular Biology and 5 papers in Sociology and Political Science. Recurrent topics in Raynald Samoa's work include Metabolism, Diabetes, and Cancer (7 papers), Racial and Ethnic Identity Research (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Raynald Samoa is often cited by papers focused on Metabolism, Diabetes, and Cancer (7 papers), Racial and Ethnic Identity Research (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Raynald Samoa collaborates with scholars based in United States, Taiwan and New Zealand. Raynald Samoa's co-authors include Ken C. Chiu, Neal A. Palafox, Joseph Keawe‘aimoku Kaholokula, Smita Bhatia, Saro H. Armenian, E Blum, Kalyanasundaram Venkataraman, Can‐Lan Sun, F. Lennie Wong and Kirsten K. Ness and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Raynald Samoa

26 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raynald Samoa United States 12 88 87 80 68 67 29 470
Arnold Degboe United States 11 84 1.0× 81 0.9× 46 0.6× 18 0.3× 136 2.0× 31 600
Jaideep Menon India 14 232 2.6× 29 0.3× 26 0.3× 12 0.2× 31 0.5× 53 638
Jonathan Witonsky United States 6 34 0.4× 16 0.2× 32 0.4× 47 0.7× 49 0.7× 8 445
Nikhil K. Mull United States 9 31 0.4× 39 0.4× 16 0.2× 31 0.5× 76 1.1× 22 437
Anne-Marie Dyer United States 15 57 0.6× 18 0.2× 143 1.8× 34 0.5× 99 1.5× 24 704
Anthony Proietto Australia 16 46 0.5× 42 0.5× 53 0.7× 26 0.4× 155 2.3× 41 671
Nancy D. Barker United States 13 66 0.8× 17 0.2× 23 0.3× 46 0.7× 20 0.3× 24 500
Luz-Ma-Adriana Balderas-Peña Mexico 13 156 1.8× 29 0.3× 32 0.4× 8 0.1× 140 2.1× 41 630
Aleksei Baburin Estonia 13 76 0.9× 61 0.7× 24 0.3× 10 0.1× 142 2.1× 49 498
Míriam Barrecheguren Spain 19 30 0.3× 28 0.3× 23 0.3× 24 0.4× 175 2.6× 89 1.2k

Countries citing papers authored by Raynald Samoa

Since Specialization
Citations

This map shows the geographic impact of Raynald Samoa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raynald Samoa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raynald Samoa more than expected).

Fields of papers citing papers by Raynald Samoa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raynald Samoa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raynald Samoa. The network helps show where Raynald Samoa may publish in the future.

Co-authorship network of co-authors of Raynald Samoa

This figure shows the co-authorship network connecting the top 25 collaborators of Raynald Samoa. A scholar is included among the top collaborators of Raynald Samoa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raynald Samoa. Raynald Samoa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Artz, Andrew, et al.. (2025). SGLT2 Inhibitor–Associated Euglycemic Diabetic Ketoacidosis (EDKA) in Hematologic Malignancy Patients: A Case Series. Advances in Hematology. 2025(1). 7244013–7244013.
2.
Firestone, Ridvan, Soo Cheng, Marine Corbin, et al.. (2025). A feasibility study investigating the risk of prediabetes among children in New Zealand. Scientific Reports. 15(1). 31360–31360. 1 indexed citations
3.
4.
Behrendt, Carolyn E., Susan E. Yost, Niki Patel, et al.. (2023). Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer. The Oncologist. 28(7). e488–e492. 5 indexed citations
5.
Chen, Zhuo, et al.. (2022). Asian American, Native Hawaiian, and Pacific Islander Health. Health Equity. 6(1). 942–952. 1 indexed citations
6.
Ou, Horng‐Yih, et al.. (2022). The impact of glucose tolerance state on seropositivity rate after hepatitis B vaccination. Scientific Reports. 12(1). 3087–3087. 1 indexed citations
7.
Saw, Anne, Stella S. Yi, Lan N. Ðoàn, et al.. (2022). Improving Asian American health during the Syndemic of COVID-19 and racism. EClinicalMedicine. 45. 101313–101313. 26 indexed citations
8.
Grills, Cheryl, Anne Saw, Karina L. Walters, et al.. (2022). Applying culturalist methodologies to discern COVID‐19's impact on communities of color. Journal of Community Psychology. 51(6). 2331–2354. 20 indexed citations
9.
Pattan, Vishwanath, Ken C. Chiu, & Raynald Samoa. (2021). Recurrent, refractory hypokalemia as a diagnostic clue to thyrotoxic periodic paralysis in a patient with acute kidney injury and suspected Guillain‐Barre syndrome. SHILAP Revista de lepidopterología. 9(6). e04443–e04443. 2 indexed citations
10.
Lin, James, et al.. (2021). Role of hepatitis A virus in diabetes mellitus. World Journal of Diabetes. 12(11). 1928–1941. 2 indexed citations
11.
Kaholokula, Joseph Keawe‘aimoku, et al.. (2020). COVID-19 Special Column: COVID-19 Hits Native Hawaiian and Pacific Islander Communities the Hardest.. PubMed. 79(5). 144–146. 75 indexed citations
12.
Samoa, Raynald, et al.. (2020). Anti–PD-1 Therapy–Associated Type 1 Diabetes in a Pediatric Patient With Relapsed Classical Hodgkin Lymphoma. Diabetes Care. 43(9). 2293–2295. 19 indexed citations
13.
Hawley, Nicola L., Haley L. Cash, Nia Aitaoto, et al.. (2019). Diabetes Prevention and Care Programs in the US-Affiliated Pacific Islands: Challenges, Innovation, and Recommendations for Effective Scale-Up. Current Diabetes Reports. 19(5). 24–24. 4 indexed citations
14.
Mekraksakit, Poemlarp, et al.. (2019). Prognosis of Differentiated Thyroid Carcinoma in Patients with Graves Disease: A Systematic Review and Meta-Analysis. Endocrine Practice. 25(12). 1323–1337. 18 indexed citations
15.
Ou, Horng-Yih, James Lin, Wei Feng, et al.. (2015). The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination. PLoS ONE. 10(10). e0139730–e0139730. 13 indexed citations
16.
Ou, Horng-Yih, et al.. (2014). Clinical implication of fasting and post-challenged plasma glucose in diagnosis of diabetes mellitus. Endocrine. 48(2). 511–518. 9 indexed citations
17.
Samoa, Raynald, et al.. (2014). The Role ofHelicobacter pyloriSeropositivity in Insulin Sensitivity, Beta Cell Function, and Abnormal Glucose Tolerance. Scientifica. 2014. 1–7. 18 indexed citations
18.
Salehian, Behrouz & Raynald Samoa. (2013). RET Gene Abnormalities and Thyroid Disease: Who Should be Screened and When. Journal of Clinical Research in Pediatric Endocrinology. 5(1). 70–78. 12 indexed citations
19.
Fujimoto, Wilfred Y., et al.. (2013). Gestational Diabetes in High-Risk Populations. Clinical Diabetes. 31(2). 90–94. 26 indexed citations
20.
Armenian, Saro H., Can‐Lan Sun, Kirsten K. Ness, et al.. (2012). Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood. 120(23). 4505–4512. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnold Degboe Breakdown of academic impact, for papers by Jaideep Menon Breakdown of academic impact, for papers by Jonathan Witonsky Breakdown of academic impact, for papers by Nikhil K. Mull Breakdown of academic impact, for papers by Anne-Marie Dyer Breakdown of academic impact, for papers by Anthony Proietto Breakdown of academic impact, for papers by Nancy D. Barker Breakdown of academic impact, for papers by Luz-Ma-Adriana Balderas-Peña Breakdown of academic impact, for papers by Aleksei Baburin Breakdown of academic impact, for papers by Míriam Barrecheguren
Rankless by CCL
2026